AdvanCell

Sydney, Australia · Founded 2019 · Privately Held (backing)

Operator of a radiopharmaceutical company intended for developing alpha therapies for cancer patients. AdvanCell is based in Sydney, Australia and was founded in 2019. Its last reported valuation was $165 million in Jun 2025. It has raised $132 million.

Last reported valuation

$165.0M

Oct 2026

Priced at

—

Total raised

$132.3M

Last round

—

How much has AdvanCell raised?

$132.3Macross 0 recorded rounds

Free account

More of AdvanCell with a free account

·The complete investor list: 18 names
·Watch AdvanCell: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AdvanCell investors

18 investors are on record for AdvanCell, including Catalio Capital Management, Morningside Group, SV Health Investors and Brandon Capital.

For fundraisers

Raising for a company like AdvanCell?

18 investors have backed AdvanCell.

See all 18 investors →

Frequently asked about AdvanCell

How much has AdvanCell raised?: AdvanCell has raised $132.3M in total across 0 recorded funding rounds.